Alaffia Health is a New York-based healthtech company that uses agentic AI paired with expert clinicians to help health insurers detect and stop waste, fraud, and abuse in medical claims. Its Autodor platform forensically reviews complete patient medical records against submitted claims to power payment integrity, utilization management, and appeals workflows - reviewing complex facility claims up to 20x faster than manual processes while keeping humans in the loop for defensible, explainable outcomes.
H1 is a New York-based healthcare data and technology company that maps the world's healthcare professionals, clinical trials and provider networks into a single platform. Founded in 2017 by Ariel Katz and Ian Sax, H1 aggregates billions of data points - peer-reviewed publications, clinical trial records, medical claims and provider directories - so pharmaceutical, biotech, medtech, health-plan and digital-health customers can find the right doctors, run better clinical trials, engage key opinion leaders and keep provider information accurate. Its stated mission is to create a healthier future by making healthcare information and evidence-based medicine accessible globally.
TJ Ademiluyi is the CEO and co-founder of Alaffia Health, a New York healthcare-technology company that pairs licensed clinicians with agentic AI to review medical claims for health plans. Raised in a family that ran a medical-billing business, he traded a finance career at Goldman Sachs to build software that reads patient records, checks provider bills against policy, and flags overpayments before they are paid. He founded the company in 2020 with his older sister, Adun Akanni, was named to Forbes' 2023 30 Under 30 in Healthcare, and in February 2026 raised a $55 million Series B led by Transformation Capital, bringing total funding above $73 million.